Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Cerebrovascular Disorders

Free Subscription Articles published in Lancet Retrieve available abstracts of 70 articles: HTML format

Single Articles

March 2026
1. DELEWI R, Aarts HM, Broeze GM, Hemelrijk KI, et al
   Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial.
   Lancet. 2026 Mar 29:S0140-6736(26)00308-9. doi: 10.1016/S0140-6736(26)00308.
   PubMed     Abstract available
   
   
   
2. KANG J, Park S, Yang HM, Shin ES, et al
   Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial.
   Lancet. 2026 Mar 29:S0140-6736(26)00422-8. doi: 10.1016/S0140-6736(26)00422.
   PubMed     Abstract available
   
   
   
3. COLOMBATTI R, Jastaniah W, Makani J, Andemariam B, et al
   Sickle cell disease.
   Lancet. 2026;407:1095-1111.
   PubMed     Abstract available
   
   
   
4. LANE DA, Andrade JG, Arbelo E, Boriani G, et al
   Atrial fibrillation.
   Lancet. 2026;407:1000-1013.
   PubMed     Abstract available
   
   
   February 2026
5. WANG N, Salam A, Rodgers A
   Simplifying and improving heart attack and stroke prevention - Authors' reply.
   Lancet. 2026;407:572.
   PubMed    
   
   
   
6. WALD NJ, Hingorani AD, Morris JK
   Simplifying and improving heart attack and stroke prevention.
   Lancet. 2026;407:571-572.
   PubMed    
   
   
   
7. TSIVGOULIS G, Palaiodimou L, Turc G
   Intravenous tenecteplase for acute ischaemic stroke within 24 h due to basilar artery occlusion.
   Lancet. 2026 Feb 5:S0140-6736(26)00139-X. doi: 10.1016/S0140-6736(26)00139.
   PubMed    
   
   
   
8. XIONG Y, Alemseged F, Cao Z, Schwamm LH, et al
   Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial.
   Lancet. 2026 Feb 5:S0140-6736(25)02633-9. doi: 10.1016/S0140-6736(25)02633.
   PubMed     Abstract available
   
   
   
9. ANDERSON CS, Chen C, Salman RA
   Testing early haemostatic therapy for acute intracerebral haemorrhage.
   Lancet. 2026 Feb 4:S0140-6736(26)00146-7. doi: 10.1016/S0140-6736(26)00146.
   PubMed    
   
   
   
10. BRODERICK JP, Naidech AM, Elm JJ, Toyoda K, et al
    Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Lancet. 2026 Feb 4:S0140-6736(26)00097-8. doi: 10.1016/S0140-6736(26)00097.
    PubMed     Abstract available
    
    
    January 2026
11. LU Y, Guan L, Wu J, Yang Q, et al
    Efficacy and safety of minocycline in patients with acute ischaemic stroke (EMPHASIS): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2026 Jan 30:S0140-6736(25)01862-8. doi: 10.1016/S0140-6736(25)01862.
    PubMed     Abstract available
    
    
    December 2025
12. ANDERSON CS, Sui Y, Urrutia VC
    The importance of patient selection in stroke monitoring research - Authors' reply.
    Lancet. 2025;406:2756.
    PubMed    
    
    
    
13. HAYASHI S, Yasuda T, Shiraishi A
    The importance of patient selection in stroke monitoring research.
    Lancet. 2025;406:2755-2756.
    PubMed    
    
    
    October 2025
14. KIRBY T
    Xunming Ji: preventing and treating stroke in China.
    Lancet. 2025 Oct 27:S0140-6736(25)02176-2. doi: 10.1016/S0140-6736(25)02176.
    PubMed    
    
    
    
15. CACOUB P, Vieira M, Langford CA, Tazi Mezalek Z, et al
    Large-vessel vasculitis.
    Lancet. 2025;406:2017-2032.
    PubMed     Abstract available
    
    
    August 2025
16. CHENG SP, Chen PH, Jhou HJ
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
    Lancet. 2025;406:601.
    PubMed    
    
    
    
17. WERRING DJ, Dehbi HM, Best JG, Nash PS, et al
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke - Authors' reply.
    Lancet. 2025;406:601-602.
    PubMed    
    
    
    
18. POCAR M, Barbero C, Cerrato P, De Rosa FG, et al
    Timing of cardiac surgery and anticoagulants after acute ischaemic stroke.
    Lancet. 2025;406:600-601.
    PubMed    
    
    
    June 2025
19. ZIAI WC, Tsivgoulis G
    Timing of anticoagulation after ischaemic stroke and atrial fibrillation: better swift than sorry.
    Lancet. 2025 Jun 23:S0140-6736(25)00676-2. doi: 10.1016/S0140-6736(25)00676.
    PubMed    
    
    
    
20. DEHBI HM, Fischer U, Asberg S, Milling TJ, et al
    Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST).
    Lancet. 2025 Jun 23:S0140-6736(25)00439-8. doi: 10.1016/S0140-6736(25)00439.
    PubMed     Abstract available
    
    
    May 2025
21. ASHCRAFT S
    Safety of low-intensity monitoring after thrombolysis in acute ischaemic stroke.
    Lancet. 2025;405:1884-1885.
    PubMed    
    
    
    
22. ANDERSON CS, Summers D, Ouyang M, Sui Y, et al
    Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferio
    Lancet. 2025 May 20:S0140-6736(25)00549-5. doi: 10.1016/S0140-6736(25)00549.
    PubMed     Abstract available
    
    
    
23. SONG L, Li Q, Anderson CS
    Traditional Chinese medicine for acute intracerebral haemorrhage - Authors' reply.
    Lancet. 2025;405:1741-1742.
    PubMed    
    
    
    
24. CHEN Y, Liang X, Liu Z
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1741.
    PubMed    
    
    
    
25. XU X, Fan H, Liu Q
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1740.
    PubMed    
    
    
    
26. ZHANG F, Wang Z, Kong W, Zhang W, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1739.
    PubMed    
    
    
    
27. ZHU Y, Hu J, Ji S, Huang M, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1739-1740.
    PubMed    
    
    
    
28. FAN AY, Gu S, Gong C
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1738.
    PubMed    
    
    
    
29. JIA H, Liu W, Fan X, Li Y, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1738-1739.
    PubMed    
    
    
    
30. LUO R, Hui H, Ge H, Ran X, et al
    Traditional Chinese medicine for acute intracerebral haemorrhage.
    Lancet. 2025;405:1737-1738.
    PubMed    
    
    
    March 2025
31. CHOI KH, Park YH, Lee JY, Jeong JO, et al
    Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial.
    Lancet. 2025 Mar 28:S0140-6736(25)00449-0. doi: 10.1016/S0140-6736(25)00449.
    PubMed     Abstract available
    
    
    February 2025
32. VELTKAMP R, Korompoki E, Harvey KH, Harvey ER, et al
    Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial.
    Lancet. 2025 Feb 26:S0140-6736(25)00333-2. doi: 10.1016/S0140-6736(25)00333.
    PubMed     Abstract available
    
    
    
33. CHRISTENSON J, Hill MD, Swartz RH, Adams C, et al
    Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.
    Lancet. 2025;405:571-582.
    PubMed     Abstract available
    
    
    
34. HILL MD, Goyal M, Demchuk AM, Menon BK, et al
    Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2025;405:560-570.
    PubMed     Abstract available
    
    
    
35. KOOHI N, Simonyan S, Joffily L, Simister R, et al
    Testing hearing in suspected stroke: a diagnostic opportunity.
    Lancet. 2025;405:540-541.
    PubMed    
    
    
    
36. LI W, Lan J, Wei M, Liu L, et al
    Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial.
    Lancet. 2025;405:486-497.
    PubMed     Abstract available
    
    
    
37. DIPPEL DWJ, Janssen PM
    Effect of normobaric hyperoxia in ischaemic stroke.
    Lancet. 2025;405:442-443.
    PubMed    
    
    
    January 2025
38. FISCHER U, Butikofer L, Raabe A, Beck J, et al
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial - Authors' reply.
    Lancet. 2025;405:31-32.
    PubMed    
    
    
    
39. MARSCHNER IC
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:31.
    PubMed    
    
    
    
40. ENGRAND N, Miry L
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:30-31.
    PubMed    
    
    
    
41. FRONTERA JA, Morris NA
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:30.
    PubMed    
    
    
    
42. ROEPKE RML, Adler Maccagnan Pinheiro Besen B
    Decompressive craniectomy for people with intracerebral haemorrhage: the SWITCH trial.
    Lancet. 2025;405:29-30.
    PubMed    
    
    
    December 2024
43. HO JK, Hankey GJ
    Endovascular therapy for ischaemic stroke due to vertebrobasilar artery occlusion.
    Lancet. 2024 Dec 11:S0140-6736(24)02137-8. doi: 10.1016/S0140-6736(24)02137.
    PubMed    
    
    
    
44. NOGUEIRA RG, Jovin TG, Liu X, Hu W, et al
    Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis.
    Lancet. 2024 Dec 11:S0140-6736(24)01820-8. doi: 10.1016/S0140-6736(24)01820.
    PubMed     Abstract available
    
    
    November 2024
45. DHILLON PS, Nguyen TN
    Temporary blood flow arrest during endovascular thrombectomy for acute ischaemic stroke.
    Lancet. 2024 Nov 20:S0140-6736(24)02461-9. doi: 10.1016/S0140-6736(24)02461.
    PubMed    
    
    
    
46. LIU J, Zhou Y, Zhang L, Li Z, et al
    Balloon guide catheters for endovascular thrombectomy in patients with acute ischaemic stroke due to large-vessel occlusion in China (PROTECT-MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Lancet. 2024 Nov 20:S0140-6736(24)02315-8. doi: 10.1016/S0140-6736(24)02315.
    PubMed     Abstract available
    
    
    
47. WU S
    Integrative medicine for the treatment of stroke.
    Lancet. 2024 Nov 12:S0140-6736(24)02257-8. doi: 10.1016/S0140-6736(24)02257.
    PubMed    
    
    
    
48. GUO J, Chen X, Wu M, Wang D, et al
    Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial.
    Lancet. 2024 Nov 12:S0140-6736(24)02261-X. doi: 10.1016/S0140-6736(24)02261.
    PubMed     Abstract available
    
    
    
49. WOLF ME, Roser E, Bazner H
    Embolic stroke and patent foramen ovale in a 43-year-old fan chanting during a football match.
    Lancet. 2024;404:1760.
    PubMed    
    
    
    
50. THOMALLA G, Bonekamp S, Fiehler J, Bendszus M, et al
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial - Authors' reply.
    Lancet. 2024;404:1729-1730.
    PubMed    
    
    
    
51. JHOU HJ, Yang LY, Chen PH
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728.
    PubMed    
    
    
    
52. WANG Z, Huang K, Huang ZX
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1728-1729.
    PubMed    
    
    
    
53. BROOCKS G, Kemmling A
    Endovascular thrombectomy for acute ischaemic stroke: the TENSION trial.
    Lancet. 2024;404:1727-1728.
    PubMed    
    
    
    October 2024
54. WERRING DJ, Dehbi HM, Ahmed N, Arram L, et al
    Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
    Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197.
    PubMed     Abstract available
    
    
    
55. SANDSET EC, de Sousa DA
    Optimal anticoagulation timing after ischaemic stroke in patients with atrial fibrillation.
    Lancet. 2024 Oct 23:S0140-6736(24)02259-1. doi: 10.1016/S0140-6736(24)02259.
    PubMed    
    
    
    September 2024
56. NGUYEN TN, Abdalkader M, Fischer U, Qiu Z, et al
    Endovascular management of acute stroke.
    Lancet. 2024;404:1265-1278.
    PubMed     Abstract available
    
    
    
57. PREVEL R, Boyer A, Gruson D, Orieux A, et al
    Catheter ablation for atrial fibrillation, atrio-oesophageal fistula, cerebral air embolism, and hyperbaric oxygen therapy.
    Lancet. 2024;404:1051-1052.
    PubMed    
    
    
    August 2024
58. CASADO-NARANJO I, Portilla-Cuenca JC, Duarte-Martin JJ, Moyano-Calvente SL, et al
    Multiple intracerebral haemorrhages and ubiquitous brain microbleeds in a patient with Down syndrome: cerebral amyloid angiopathy.
    Lancet. 2024;404:e4.
    PubMed    
    
    
    
59. JAVED S, Zaidi DA, Yaqoob E
    Addressing the deficiencies in stroke care in Pakistan.
    Lancet. 2024;404:651-652.
    PubMed    
    
    
    June 2024
60. RAJ R, Tommiska P, Koivisto T, Leinonen V, et al
    Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH): a Finnish, nationwide, parallel-group, multicentre, randomised, controlled, non-inferiority trial.
    Lancet. 2024;403:2798-2806.
    PubMed     Abstract available
    
    
    
61. SHIBAHASHI K
    Optimising treatment for chronic subdural haematoma.
    Lancet. 2024;403:2757-2759.
    PubMed    
    
    
    
62. LIU J, Li Y, Ge J, Yan X, et al
    Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial.
    Lancet. 2024 Jun 27:S0140-6736(24)01028-6. doi: 10.1016/S0140-6736(24)01028.
    PubMed     Abstract available
    
    
    
63. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    PubMed     Abstract available
    
    
    
64. KATSANOS AH, Shoamanesh A
    Colchicine for the prevention of vascular events after non-cardioembolic stroke.
    Lancet. 2024 Jun 7:S0140-6736(24)01096-1. doi: 10.1016/S0140-6736(24)01096.
    PubMed    
    
    
    May 2024
65. COUTTS SB, Ankolekar S, Appireddy R, Arenillas JF, et al
    Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
    Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921.
    PubMed     Abstract available
    
    
    
66. SACCO S, Turc G
    Advances and challenges in the acute treatment of minor ischaemic stroke.
    Lancet. 2024 May 16:S0140-6736(24)00981-4. doi: 10.1016/S0140-6736(24)00981.
    PubMed    
    
    
    
67. HILKENS NA, Casolla B, Leung TW, de Leeuw FE, et al
    Stroke.
    Lancet. 2024 May 14:S0140-6736(24)00642-1. doi: 10.1016/S0140-6736(24)00642.
    PubMed     Abstract available
    
    
    
68. BECK J, Fung C, Strbian D, Butikofer L, et al
    Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial.
    Lancet. 2024 May 14:S0140-6736(24)00702-5. doi: 10.1016/S0140-6736(24)00702.
    PubMed     Abstract available
    
    
    
69. KLIJN CJ, Dammers R, Sprigg N
    Decompressive craniectomy for deep intracerebral haemorrhage: a SWITCH towards better outcomes?
    Lancet. 2024 May 14:S0140-6736(24)00703-7. doi: 10.1016/S0140-6736(24)00703.
    PubMed    
    
    
    March 2024
70. MELLO A, Stehr D, Bujarski K, Duchaine B, et al
    Visualising facial distortions in prosopometamorphopsia.
    Lancet. 2024;403:1176.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cerebrovascular Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum